{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T21:33:49Z","timestamp":1772314429447,"version":"3.50.1"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejps.2023.106492","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T11:22:28Z","timestamp":1686396148000},"page":"106492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Determining optimal combination regimens for patients with multiple myeloma"],"prefix":"10.1016","volume":"187","author":[{"given":"Mahya","family":"Aghaee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urszula","family":"Ledzewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Bezman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hearn","family":"Jay Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106492_bib0001","series-title":"Cellular and Molecular Immunology","author":"Abbas","year":"2022"},{"issue":"4","key":"10.1016\/j.ejps.2023.106492_bib0002","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1137\/21M1393315","volume":"59","author":"Aghaee","year":"2021","journal-title":"SIAM J. Control Optim."},{"issue":"4","key":"10.1016\/j.ejps.2023.106492_bib0003","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41408-019-0205-9","volume":"9","author":"Al Hamed","year":"2019","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ejps.2023.106492_bib0004","author":"Atkins"},{"key":"10.1016\/j.ejps.2023.106492_bib0005","unstructured":"Australian public assessment report for elotuzumab, 31-10-2017. https:\/\/www.tga.gov.au\/resources\/auspar\/auspar-elotuzumab."},{"issue":"3","key":"10.1016\/j.ejps.2023.106492_bib0006","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.ejps.2023.106492_bib0007","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/10428199809059231","volume":"31","author":"Brown","year":"1998","journal-title":"Leukemia Lymphoma"},{"issue":"10","key":"10.1016\/j.ejps.2023.106492_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-022-00738-x","volume":"10","author":"Bunce","year":"2020","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.ejps.2023.106492_bib0009","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood-2004-04-1422","volume":"105","author":"Carbone","year":"2005","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.ejps.2023.106492_bib0010","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1073\/pnas.201238598","volume":"98","author":"Cerwenka","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2023.106492_bib0011","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood-2005-10-4184","volume":"9","author":"Chang","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ejps.2023.106492_bib0012","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1073\/pnas.0408197102","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2023.106492_bib0013","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.chemosphere.2015.09.089","volume":"144","author":"Chen","year":"2016","journal-title":"Chemosphere"},{"issue":"8","key":"10.1016\/j.ejps.2023.106492_bib0014","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","volume":"21","author":"Citron","year":"2003","journal-title":"JCO"},{"key":"10.1016\/j.ejps.2023.106492_bib0015","first-page":"e1066062","volume":"3","author":"Cook","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ejps.2023.106492_bib0016","first-page":"380","volume":"1","author":"Corral","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2023.106492_bib0017","unstructured":"Current FDA-approved medications, 2023-03-24. https:\/\/www.myeloma.org\/multiple-myeloma-drugs."},{"key":"10.1016\/j.ejps.2023.106492_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/9271469","volume":"2016","author":"D\u2019Arena","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.ejps.2023.106492_bib0019","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood.V98.1.210","volume":"98","author":"Davies","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.ejps.2023.106492_bib0020","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1084\/jem.20021650","volume":"197","author":"Dhodapkar","year":"2003","journal-title":"J. Exp. Med."},{"issue":"6852","key":"10.1016\/j.ejps.2023.106492_bib0021","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35093109","volume":"413","author":"Diefenbach","year":"2001","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ejps.2023.106492_bib0022","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.4049\/jimmunol.175.11.7135","volume":"175","author":"DiPaolo","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2023.106492_bib0023","first-page":"2286","volume":"13","author":"DM Jr","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ejps.2023.106492_sbref0022","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.32","volume":"5","author":"Dosani","year":"2015","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.ejps.2023.106492_bib0025","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejps.2023.106492_bib0026","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cam4.3444","volume":"10","author":"Ellington","year":"2021","journal-title":"Cancer Med."},{"issue":"21","key":"10.1016\/j.ejps.2023.106492_bib0027","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1182\/blood.V124.21.5712.5712","volume":"124","author":"Endell","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejps.2023.106492_bib0028","unstructured":"Committee for medicinal products for human use CHMP, european medicine agency, 2022. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/xenpozyme."},{"issue":"5","key":"10.1016\/j.ejps.2023.106492_bib0029","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3109\/10428194.2013.825905","volume":"55","author":"Favaloro","year":"2014","journal-title":"Leukemia Lymphoma"},{"key":"10.1016\/j.ejps.2023.106492_bib0030","unstructured":"Fda approves first treatment for acid sphingomyelinase deficiency, a rare genetic disease, 2022. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-acid-sphingomyelinase-deficiency-rare-genetic-disease."},{"issue":"5","key":"10.1016\/j.ejps.2023.106492_bib0031","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2141.2008.07530.x","volume":"144","author":"Feyler","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.ejps.2023.106492_bib0032","doi-asserted-by":"crossref","first-page":"e35981","DOI":"10.1371\/journal.pone.0035981","volume":"7","author":"Feyler","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.ejps.2023.106492_bib0033","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2141.2002.03879.x","volume":"119","author":"Frohn","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejps.2023.106492_bib0034","series-title":"Understanding complex biological systems with mathematics","author":"Gallaher","year":"2018"},{"key":"10.1016\/j.ejps.2023.106492_bib0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtbi.2018.08.037","volume":"458","author":"Gallaher","year":"2018","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.ejps.2023.106492_bib0036","first-page":"811","volume":"9","author":"Gandhi","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.ejps.2023.106492_bib0037","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/abbs\/gmu041","volume":"46","author":"Gao","year":"2014","journal-title":"ABBS"},{"issue":"17","key":"10.1016\/j.ejps.2023.106492_bib0038","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.3390\/cancers13174320","volume":"13","author":"Gengenbach","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ejps.2023.106492_bib0039","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-065X.2006.00445.x","volume":"214","author":"Ghiringhelli","year":"2006","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.ejps.2023.106492_bib0040","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.20051511","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.ejps.2023.106492_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-018-3546-8","volume":"98","author":"Goldschmidt","year":"2019","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ejps.2023.106492_bib0042","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s11425-016-0300-6","volume":"59","author":"Hager","year":"2016","journal-title":"Sci. China Math."},{"key":"10.1016\/j.ejps.2023.106492_bib0043","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1634\/theoncologist.2014-0073","volume":"3","author":"Hanaizi","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.ejps.2023.106492_bib0044","first-page":"7540","volume":"15","author":"Hayashi","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2023.106492_bib0045","unstructured":"Highlights of prescribing information for dexamethasone, 2019. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/labe\/2004\/11664slr062_decadron_lbl.pdf."},{"key":"10.1016\/j.ejps.2023.106492_bib0046","unstructured":"Highlights of prescribing information for elotuzumab, 2022. https:\/\/packageinserts.bms.com\/pi\/pi_empliciti.pdf."},{"issue":"9","key":"10.1016\/j.ejps.2023.106492_bib0047","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3390\/jcm10091926","volume":"10","author":"Inaba","year":"2021","journal-title":"J. Clin. Med."},{"issue":"13","key":"10.1016\/j.ejps.2023.106492_bib0048","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S1286-4579(01)01477-0","volume":"3","author":"Janeway","year":"2001","journal-title":"Microbes Infect."},{"issue":"5","key":"10.1016\/j.ejps.2023.106492_bib0049","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3390\/jcm9051314","volume":"9","author":"Jarrett","year":"2020","journal-title":"JCM"},{"key":"10.1016\/j.ejps.2023.106492_bib0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1049\/ip-syb:20050043","volume":"152","author":"Kansal","year":"2005","journal-title":"IEE Proc. Syst. Biol."},{"issue":"2","key":"10.1016\/j.ejps.2023.106492_bib0051","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijrobp.2016.06.2448","volume":"96","author":"Karlsson","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9","key":"10.1016\/j.ejps.2023.106492_bib0052","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.4049\/jimmunol.167.9.5247","volume":"167","author":"Kawarada","year":"2001","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.ejps.2023.106492_bib0053","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol."},{"issue":"2","key":"10.1016\/j.ejps.2023.106492_bib0054","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ni1428","volume":"8","author":"Kim","year":"2007","journal-title":"Nat. Immunol."},{"issue":"18","key":"10.1016\/j.ejps.2023.106492_bib0055","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.3390\/jcm10184088","volume":"10","author":"Kleber","year":"2021","journal-title":"JCM"},{"issue":"1","key":"10.1016\/j.ejps.2023.106492_bib0056","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/leu.2011.196","volume":"26","author":"Kumar","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.ejps.2023.106492_bib0057","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood-2003-02-0361","volume":"4","author":"LeBlanc","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejps.2023.106492_bib0058","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2141.2001.02995.x","volume":"114","author":"Lehmann","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejps.2023.106492_bib0059","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1051\/mmnp\/2020008","volume":"15","author":"Leszczynski","year":"2020","journal-title":"Math. Model. Nat. Phenom."},{"issue":"1","key":"10.1016\/j.ejps.2023.106492_bib0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2006.04.015","volume":"25","author":"Mempel","year":"2006","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.ejps.2023.106492_bib0061","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s002620050493","volume":"46","author":"Meropol","year":"1998","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.ejps.2023.106492_bib0062","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.amjmed.2022.08.030","volume":"136","author":"Mikhael","year":"2023","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejps.2023.106492_bib0063","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10928-018-9568-y","volume":"45","author":"Moore","year":"2018","journal-title":"J. Pharmacokinet Pharmacodyn."},{"issue":"5","key":"10.1016\/j.ejps.2023.106492_bib0064","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00285-018-1262-6","volume":"77","author":"Moore","year":"2018","journal-title":"J. Math. Biol."},{"key":"10.1016\/j.ejps.2023.106492_bib0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrclinonc.2017.82","volume":"14","author":"Morgan","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ejps.2023.106492_bib0066","doi-asserted-by":"crossref","first-page":"e47077","DOI":"10.1371\/journal.pone.0047077","volume":"7","author":"Muthu Raja","year":"2012","journal-title":"PLoS ONE"},{"issue":"21","key":"10.1016\/j.ejps.2023.106492_bib0067","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood.2020006200","volume":"136","author":"Naeimi Kararoudi","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejps.2023.106492_bib0068","first-page":"3","volume":"9","author":"Padala","year":"2021","journal-title":"Med. Sci."},{"key":"10.1016\/j.ejps.2023.106492_bib0069","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00251","volume":"7","author":"Pallmer","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2023.106492_bib0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/373123a0","volume":"373","author":"Perelson","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2023.106492_bib0071","unstructured":"Pomalyst u.s. prescribing information, bristol-myers squibb, 2020. https:\/\/packageinserts.bms.com\/pi\/pi_pomalyst.pdf."},{"issue":"5","key":"10.1016\/j.ejps.2023.106492_bib0072","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2141.2007.06705.x","volume":"138","author":"Pratt","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106492_bib0073","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hon.704","volume":"21","author":"Raitakari","year":"2003","journal-title":"Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.ejps.2023.106492_bib0074","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41408-020-00359-2","volume":"10","author":"Rajkumar","year":"2020","journal-title":"Blood Cancer J."},{"issue":"12","key":"10.1016\/j.ejps.2023.106492_bib0075","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1016\/S2352-3026(15)00197-0","volume":"2","author":"Richardson","year":"2015","journal-title":"Lancet Haematol."},{"issue":"2","key":"10.1016\/j.ejps.2023.106492_bib0076","first-page":"135","volume":"10","author":"Salmon","year":"1973","journal-title":"Semin Hematol."},{"issue":"6","key":"10.1016\/j.ejps.2023.106492_bib0077","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1172\/JCI106327","volume":"49","author":"Salmon","year":"1970","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2023.106492_bib0078","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1124\/jpet.102.048496","volume":"3","author":"Schafer","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.ejps.2023.106492_bib0079","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2567.2009.03150.x","volume":"129","author":"Shanker","year":"2010","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.ejps.2023.106492_bib0080","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.4049\/jimmunol.179.10.6651","volume":"179","author":"Shanker","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2023.106492_bib0081","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1182\/blood-2007-11-124156","volume":"4","author":"Sharma","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejps.2023.106492_bib0082","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.0105-2896.2006.00415.x","volume":"212","author":"Shevach","year":"2006","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.ejps.2023.106492_bib0083","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1399-0039.2011.01796.x","volume":"78","author":"Shook","year":"2011","journal-title":"Tissue Antigens"},{"issue":"3","key":"10.1016\/j.ejps.2023.106492_bib0084","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4049\/jimmunol.176.3.1582","volume":"176","author":"Smyth","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2023.106492_bib0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/ejh.13839","volume":"5","author":"Soekojo","year":"2022","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ejps.2023.106492_bib0086","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/ejh.13840","volume":"5","author":"Soekojo","year":"2022","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ejps.2023.106492_bib0087","series-title":"Infinite powers: How calculus reveals the secrets of the universe","author":"Strogatz","year":"2019"},{"issue":"8","key":"10.1016\/j.ejps.2023.106492_bib0088","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/leu.2016.84","volume":"30","author":"Suen","year":"2016","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.ejps.2023.106492_bib0089","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1172\/JCI106971","volume":"51","author":"Sullivan","year":"1972","journal-title":"J. Clin. Invest."},{"issue":"18","key":"10.1016\/j.ejps.2023.106492_bib0090","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1073\/pnas.1218767110","volume":"110","author":"Sungur","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.ejps.2023.106492_bib0091","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0092-8240(77)80070-0","volume":"39","author":"Swan","year":"1977","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.ejps.2023.106492_bib0092","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2007-08-107292","volume":"4","author":"Tai","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejps.2023.106492_bib0093","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jmcb\/mjr033","volume":"4","author":"Tran","year":"2012","journal-title":"J. Mol. Cell Biol."},{"issue":"45","key":"10.1016\/j.ejps.2023.106492_bib0094","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.18632\/oncotarget.27792","volume":"11","author":"Verkleij","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejps.2023.106492_bib0095","first-page":"1","volume":"3","author":"Weisel","year":"2023","journal-title":"Hemasphere"},{"issue":"9","key":"10.1016\/j.ejps.2023.106492_bib0096","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1182\/blood.V99.9.3280","volume":"99","author":"Wen","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ejps.2023.106492_bib0097","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.7150\/ijbs.68148","volume":"18","author":"Wu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejps.2023.106492_bib0098","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/10428194.2012.728597","volume":"4","author":"Zhu","year":"2013","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.ejps.2023.106492_bib0099","first-page":"683","volume":"36","author":"ZShortt","year":"2013","journal-title":"Oncogene"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723001227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723001227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:10:46Z","timestamp":1760530246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723001227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":99,"alternative-id":["S0928098723001227"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106492","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determining optimal combination regimens for patients with multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106492"}}